Canadian Chronic Disease Surveillance System (CCDSS)

Select item(s) from each list below:

Geography

Condition

Measure

Sex
Both sexes
Males Females
Use the same vertical axis scale across all sex categories

Optional:

Year range

Scale
Use the same vertical axis scale across all geographic areas

Chart type
Line Bar

For more information on the interpretation of the data please see the notes below.

Summary Table: Diabetes mellitus (types combined), excluding gestational diabetes, age-standardized incidence rate, per 100,000, age 1 year and older, Canada
Sex	Fiscal year	Rate (per 100,000)	95% CI	CV (%)	Counts
Both sexes	2000–2001	656	653–659	0.25	163,435
Both sexes	2001–2002	670	667–674	0.25	170,665
Both sexes	2002–2003	684	681–687	0.24	177,375
Both sexes	2003–2004	665	662–669	0.24	175,570
Both sexes	2004–2005	696	693–700	0.23	186,355
Both sexes	2005–2006	724	721–728	0.23	197,335
Both sexes	2006–2007	759	755–762	0.22	208,760
Both sexes	2007–2008	715	712–718	0.23	199,720
Both sexes	2008–2009	705	702–709	0.22	203,505
Both sexes	2009–2010	745	742–748	0.21	218,725
Both sexes	2010–2011	691	688–694	0.22	206,790
Both sexes	2011–2012	667	664–670	0.22	203,475
Both sexes	2012–2013	623	620–626	0.23	193,940
Both sexes	2013–2014	632	629–635	0.22	200,695
Both sexes	2014–2015	620	618–623	0.22	200,440
Both sexes	2015–2016	619	616–622	0.22	203,465
Both sexes	2016–2017	622	620–625	0.22	208,140
Both sexes	2017–2018	603	600–606	0.22	204,870
Both sexes	2018–2019	608	605–610	0.22	209,975
Both sexes	2019–2020	619	616–621	0.22	217,880
Both sexes	2020–2021*	571	568–573	0.22	202,330
Both sexes	2021–2022*	660	657–662	0.21	233,130
Both sexes	2022–2023*	686	683–689	0.20	247,720
Males	2000–2001	752	747–757	0.35	86,965
Males	2001–2002	770	765–775	0.34	91,220
Males	2002–2003	778	773–783	0.33	94,070
Males	2003–2004	752	747–757	0.34	92,660
Males	2004–2005	782	777–787	0.33	98,060
Males	2005–2006	816	811–821	0.32	104,140
Males	2006–2007	867	862–872	0.30	111,860
Males	2007–2008	821	816–826	0.31	107,685
Males	2008–2009	808	803–812	0.31	109,615
Males	2009–2010	856	851–861	0.29	118,355
Males	2010–2011	798	793–802	0.30	112,460
Males	2011–2012	767	762–771	0.30	110,250
Males	2012–2013	718	714–723	0.31	105,645
Males	2013–2014	727	722–731	0.31	108,990
Males	2014–2015	714	710–719	0.31	109,170
Males	2015–2016	715	711–720	0.30	111,480
Males	2016–2017	718	713–722	0.30	113,860
Males	2017–2018	697	693–701	0.30	112,390
Males	2018–2019	708	704–712	0.30	116,255
Males	2019–2020	719	715–724	0.29	120,365
Males	2020–2021*	658	654–662	0.30	111,025
Males	2021–2022*	747	743–751	0.28	125,575
Males	2022–2023*	766	762–771	0.28	131,410
Females	2000–2001	571	567–575	0.37	76,465
Females	2001–2002	583	579–587	0.36	79,450
Females	2002–2003	601	597–605	0.35	83,305
Females	2003–2004	590	585–594	0.35	82,910
Females	2004–2005	620	616–624	0.34	88,295
Females	2005–2006	643	639–648	0.33	93,190
Females	2006–2007	662	658–667	0.32	96,900
Females	2007–2008	621	617–625	0.33	92,040
Females	2008–2009	614	610–618	0.33	93,890
Females	2009–2010	646	642–650	0.32	100,375
Females	2010–2011	596	592–600	0.33	94,330
Females	2011–2012	579	575–582	0.33	93,225
Females	2012–2013	537	534–541	0.34	88,295
Females	2013–2014	548	544–551	0.33	91,700
Females	2014–2015	536	533–540	0.33	91,270
Females	2015–2016	533	529–536	0.33	91,990
Females	2016–2017	537	534–541	0.33	94,280
Females	2017–2018	519	515–522	0.33	92,485
Females	2018–2019	517	514–521	0.33	93,715
Females	2019–2020	528	525–532	0.32	97,515
Females	2020–2021*	492	489–495	0.33	91,310
Females	2021–2022*	582	579–586	0.31	107,555
Females	2022–2023*	615	612–619	0.30	116,310

Download Detailed Table:
Diabetes mellitus (types combined), excluding gestational diabetes, age-standardized incidence rate

Download Summary Table

Notes:

*Many CCDSS measures, such as chronic disease incidence, were influenced by the COVID-19 pandemic. Changes in such measures may be driven by multiple factors, including (but not limited to) differences in healthcare seeking behaviour, the availability and use of healthcare services, as well as true changes in health status. As such, CCDSS measures should be used cautiously when making inferences about population health during the COVID-19 pandemic. Guidance for data users on examining the impacts of the COVID-19 pandemic on CCDSS measures can be accessed below.
Data suppression: Estimates are not reported when the counts are less than 10 or the coefficient of variation is greater than 33.3%.
Due to periodic updates of the historical surveillance data, estimates for a particular disease and year may change over time, and may not be comparable to previous editions.
Estimates are age-standardized to the 2011 Canadian population using unrounded counts and five-year age groups. Age-standardized estimates are useful for comparing data across years or between different geographical areas, but they do not reflect the actual impact of the disease.
Nunavut data are excluded before 2005–2006.
Newfoundland and Labrador data are excluded before 2008–2009.
Yukon data are excluded before 2010–2011.
The modernization of the Quebec billing system for fee-for-service medical services by the Régie de l'assurance maladie du Québec (RAMQ) in 2016 has resulted in a decrease in the entry of diagnostic codes in the fee-for-service medical services file. Data for 2016–2017 and subsequent years should therefore be interpreted with caution, as a slight underestimation is suspected.
The introduction of the Northwest Territories Electronic Medical Record (EMR) in 2016 resulted in more complete and consistent data. Data for 2016–2017 may be slightly underestimated compared to previous years due to the system transition.
Nova Scotia data among individuals aged 1–19 are excluded.
New Brunswick data were not available for 2021–2022 and 2022–2023.
Northwest Territories data were not available for 2022–2023.
Northwest Territories physician claim data were incomplete for 2021–2022 and should therefore be interpreted with caution, as a slight underestimation is suspected.

Source: Canadian Chronic Disease Surveillance System 2024
Methods: CCDSS Summary of Methods
Case definitions: CCDSS Case Definitions
COVID-19 Documentation: CCDSS COVID-19 guidance for data users

Acknowledgements

These data were made possible through collaboration between PHAC and the respective provincial and territorial governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Northwest Territories, Yukon, and Nunavut. No endorsement by the provinces and territories is intended or should be inferred. Provincial and territorial data were contributed to the CCDSS as of July 2024.

Did you find what you were looking for?

What was wrong?

The answer I need is missing

The information isn’t clear

I’m not in the right place

Something is broken or incorrect

Other reason

Please provide more details

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Report a problem or mistake on this page

Date modified:: 2024-10-15

Language selection

Search

Canadian Chronic Disease Surveillance System (CCDSS)

Select item(s) from each list below:

Optional:

Acknowledgements

Did you find what you were looking for?